American International Group’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,026
Closed -$239K 986
2024
Q1
$239K Sell
11,026
-97
-0.9% -$2.41K ﹤0.01% 2048
2023
Q4
$322K Sell
11,123
-102
-0.9% -$2.73K ﹤0.01% 1903
2023
Q3
$300K Buy
11,225
+264
+2% +$9.01K ﹤0.01% 1891
2023
Q2
$406K Sell
10,961
-387
-3% -$13.5K ﹤0.01% 1779
2023
Q1
$354K Buy
11,348
+60
+0.5% +$1.93K ﹤0.01% 1794
2022
Q4
$336K Sell
11,288
-426
-4% -$15.2K ﹤0.01% 1821
2022
Q3
$447K Buy
11,714
+171
+1% +$8.57K ﹤0.01% 1647
2022
Q2
$629K Sell
11,543
-301
-3% -$16.5K ﹤0.01% 1464
2022
Q1
$739K Sell
11,844
-732
-6% -$48.2K ﹤0.01% 1503
2021
Q4
$1.26M Sell
12,576
-269
-2% -$23.6K 0.01% 1279
2021
Q3
$1.16M Sell
12,845
-100
-0.8% -$9.09K 0.01% 1363
2021
Q2
$1.19K Buy
12,945
+3,582
+38% +$286K ﹤0.01% 1419
2021
Q1
$905 Buy
9,363
+276
+3% +$28.5K ﹤0.01% 1519
2020
Q4
$473 Buy
9,087
+2,218
+32% +$92.7K ﹤0.01% 1783
2020
Q3
$275K Buy
6,869
+957
+16% +$30K ﹤0.01% 1938
2020
Q2
$95K Buy
+5,912
New +$90.5K ﹤0.01% 2564
2017
Q2
Sell
-2,369
Closed -$26K 3090
2017
Q1
$26K Buy
+2,369
New +$28K ﹤0.01% 2936

Other funds holding FLGT

American International Group's FLGT Position: Q2 2024 in Review

American International Group sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 11,026 shares — an estimated $239K sold.

American International Group first reported a position in FLGT in Q1 2017 and held it in 17 quarters. The position peaked at $1.26M in Q4 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • American International Group reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 11,026 Fulgent Genetics shares in Q2 2024, an estimated $239K.
  • American International Group first reported a position in Fulgent Genetics in Q1 2017 and held it in 17 quarters.
  • American International Group's Fulgent Genetics position peaked at $1.26M in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.